Abstract
A new clinical cancer partnership in South Florida will see the Moffitt Cancer Center provide services for blood and marrow transplant and malignant hematology, as well as those related to molecular diagnostics, personalized medicine, and hematopathology to Memorial Healthcare System (MHS).
“Moffitt and Memorial share similar cultures in that we are both driven by patient-centered care, provide world-class cancer treatment, and are dedicated to advancing cancer research,” said Alan F. List, M.D., Moffitt CEO and president. “Memorial and its patients will have increased access to research, personalized medicine, and innovation through a distribution of the Moffitt model of care.”
Under the agreement, Moffitt will employ the physicians and advanced practice professionals to staff the new program at MHS. “This is the first time Moffitt-employed physicians will be practicing outside of the Tampa region and that helps us to further our legislative mandate to serve cancer patients across the state,” said Louis B. Harrison, M.D., deputy physician-in-chief and chair of Moffitt’s department of radiation oncology. Dr. Olivier Elemento, the Walter B. Wriston Research Scholar, will lead the initiative, which will involve joint work with physician-scientists at the Caryl and Israel Englander Institute for Precision Medicine and the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.
CIPhotos / Getty Images
